Korvaa consortium unveils world-first concept shoe formed from three revolutionary biomaterial technologies

Groundbreaking footwear design unites mycelium, bacterial nanocellulose, and polyhydroxyalkanoates (PHAs), signalling a new era of nature-inspired manufacturing. Concept shoe debuts at the Future Fabrics Expo, London (24-25 June 2025), inviting industry-wide collaboration in sustainable innovation. London, UK. June 24th 2025 – The Korvaa Consortium, a pioneering collaboration of biomaterial innovators, designers, and filmmakers, today unveils […]

Korvaa consortium unveils world-first concept shoe formed from three revolutionary biomaterial technologies Read More »

4D Medicine Limited to Exhibit at OMTEC 2025, Showcasing Breakthrough Biomaterials and Strategic Business Opportunities

NOTTINGHAM, UK – June 4th, 2025 – 4D Medicine Limited, a pioneering developer of advanced biomaterials for orthopaedic and surgical applications, is pleased to announce its participation as an exhibitor at the Orthopaedic Manufacturing & Technology Exposition and Conference (OMTEC) 2025, taking place June 18–19 at the Donald E. Stephens Convention Center in Chicago, Illinois.

4D Medicine Limited to Exhibit at OMTEC 2025, Showcasing Breakthrough Biomaterials and Strategic Business Opportunities Read More »

4D Biomaterials Ltd secures ISO 13485 Certification

NOTTINGHAM, UK. 3rd April, 2025 – 4D Biomaterials Ltd, the materials manufacturing subsidiary of 4D Medicine Ltd, a UK university spin-out company developing next-generation bioresorbable medical devices, today announced it has achieved ISO 13485:2016 certification from The British Standards Institution (BSI). This globally recognised quality standard for medical device manufacturing marks a critical milestone in

4D Biomaterials Ltd secures ISO 13485 Certification Read More »

4D Medicine Launches New Corporate Website to Showcase Next-Generation Bioabsorbable Polymer and Medical Device Solutions

NOTTINGHAM, UK. March 11th, 2025 – 4D Medicine Ltd, an emerging innovator in the biomaterials and medical device sector, is proud to announce the launch of its newly redesigned corporate website, www.4dmedicine.co.uk. The site is designed to offer a comprehensive resource for investors, strategic partners, and healthcare professionals, highlighting the company’s groundbreaking 4Degra® bioabsorbable polymer

4D Medicine Launches New Corporate Website to Showcase Next-Generation Bioabsorbable Polymer and Medical Device Solutions Read More »

Modern Synthesis secures $5.5M to commercialise groundbreaking biomaterial technology

Leading climate investors are backing Modern Synthesis’ biomaterial technology to reduce emissions and plastic pollution from fashion, footwear, and automotive industries. LONDON, UK. February 5th, 2025 – Modern Synthesis, a biotechnology company pioneering the development of microbially-derived biomaterials, today announces the successful close of a $5.5 million funding round. The oversubscribed round was led by

Modern Synthesis secures $5.5M to commercialise groundbreaking biomaterial technology Read More »

Modern Synthesis and GANNI reveal ‘Bou Bag’ made by bacteria for London Design Festival

Laura Johnson

Modern Synthesis and GANNI Fabrics of the Future are presenting Ganni’s staple ‘Bou Bag’ silhouette as a pilot project, in a new leather-alternative, lower impact textile made by bacteria The one-of-a-kind handbag is unveiled and on display at the London Design Festival 2023 LONDON, England, September 20, 2023 – Modern Synthesis, a biotechnology company at

Modern Synthesis and GANNI reveal ‘Bou Bag’ made by bacteria for London Design Festival Read More »